Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

DIAMOND AF Post-Approval Study

NCT: NCT05230524 · TERMINATED

NCT IDNCT05230524
StatusTERMINATED
Start Date2022-02-28
Completion2025-12-17

Brief Summary

The DIAMOND AF Post Approval study is a prospective, global, multi-center, non-randomized, single-arm observational trial

Frequently Asked Questions

What is DIAMOND AF Post-Approval Study?

DIAMOND AF Post-Approval Study is a clinical trial registered under NCT05230524. Current status: TERMINATED.

What is the status of NCT05230524?

The current status of NCT05230524 (DIAMOND AF Post-Approval Study) is: TERMINATED.

When did DIAMOND AF Post-Approval Study start?

DIAMOND AF Post-Approval Study started on 2022-02-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑